Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temocillin vs Meropenem for 3rd-gen Cephalosporin-Resistant Enterobacteriaceae Bacteremia
NCT04478721Phase 3Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Dec 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temocillin in Bacteremia, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Dec 2020; status: completed.
02
Drugs
temocillin
03
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT04478721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478721.